Verition Fund Management
SCLN

Verition Fund Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Verition Fund Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-19,852
Closed -$137K – 772
2014
Q3 		$137K Buy
+19,852
New +$119K 0.02% 611

Other funds holding SCLN

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SI
Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return

Verition Fund Management's SCLN Position: Q4 2014 in Review

Verition Fund Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2014, closing a stake of 19,852 shares — an estimated $137K sold.

Verition Fund Management first reported a position in SCLN in Q3 2014 and held it in 1 quarter. The position peaked at $137K in Q3 2014. 131 funds tracked by Wall St. Rank hold SCLN as of Q4 2014.

  • Verition Fund Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • Verition Fund Management sold 19,852 Sciclone Pharmaceuticals Inc shares in Q4 2014, an estimated $137K.
  • Verition Fund Management first reported a position in Sciclone Pharmaceuticals Inc in Q3 2014 and held it in 1 quarter.
  • Verition Fund Management's Sciclone Pharmaceuticals Inc position peaked at $137K in Q3 2014.
  • 131 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2014.

Based on Verition Fund Management's 13F filing for Q4 2014, filed 13 Feb 2015.